Neurosurgeons at the Brain Tumor Center at Lehigh Valley Cancer Institute's are using fluorescent-guided surgery to target tumors with the help of a special drug called Gleolan. Doctors say the drug ...

Hepatocellular carcinoma (HCC) is a major global health issue, with significant morbidity and mortality rates. As the sixth most common cancer and the third leading cause of cancer-related deaths, HCC ...

In cancer treatment, surgery remains the best option for removing tumors from affected patients. Successful resection is achieved by the complete removal of tumor cells so as not to cause a resurgence ...

Accurate removal of tumors is the most critical aspect of cancer surgery, yet it remains a significant challenge in clinical practice. In breast cancer, for example, the positive margin rate—where ...

Figure 1: Panel of various pediatric tumors comparing H&E staining, FRα, and FRβ protein expression within the tumor. None of these tumors demonstrate FRα expression; however all of the tumors ...

For the first time, a fluorescent-guided nerve imaging agent shows promise for use in humans, according to a paper published in Nature Communications. The study sought to evaluate the safety of ...

UNDATED HealthFirst reporter Leslie Toldo shows us how pills help light up cancer cells so they are easier to find. This development allows surgeons to remove them with more accuracy than ever before.

Fluorescent contrast agents can help identify the locations of tumors during surgery, but the contrast between tumors and healthy tissues can be reduced if a dye doesn’t specifically target a tumor.

NATICK, Mass.--(BUSINESS WIRE)--Curadel Surgical Innovations Inc., a privately held company specializing in the development of near-infrared fluorescent contrast agents for image-guided surgery, today ...

The prognosis for a cancer patient who undergoes surgery is better if the surgeon removes all of the tumor, but it can be hard to tell where a tumor ends and healthy tissue begins. Now, scientists ...